Microbiology In-Depth Focus 2018
In this In-Depth Focus; specificity in the recombinant factor C test for endotoxin, the latest trends in pharmaceutical microbiology, and the changing environment in pyrogen and endotoxin testing.
List view / Grid view
In this In-Depth Focus; specificity in the recombinant factor C test for endotoxin, the latest trends in pharmaceutical microbiology, and the changing environment in pyrogen and endotoxin testing.
In this issue; recent developments in turning promising compounds into drug candidates, reviewing the latest trends in pharmaceutical microbiology and their implications, and a roundtable debate featuring the views of five industry leaders.
The concept of developing a bioink that can be used for all cell types and all printing techniques is at best unrealistic and at worst impossible. What is much more achievable and also more desirable is a modifiable, modular system...
Novel approach enables genetic analysis of entire viral life cycle, starting with initial infection...
Wickham Laboratories Ltd will exhibit on Stand 408 at the Making Pharmaceuticals Europe Conference, from the 13 - 14 March 2018 in Belgium at Brussels Expo centre...
Scientists and chemists are re-examining old compounds to see whether they could hold the key to a future drug to combat increasingly resistant bacteria...
Technical advances in vaccine production should shorten the time to clinical trials, breaking the logjam of promising new candidate vaccines waiting to be tested...
Researchers have found a new way of accelerating wound healing using lactic acid bacteria as vectors to produce and deliver a human chemokine on site in the wounds...
Adding the targeted cancer therapy drug crizotinib to radiation therapy for tumours associated with the genetic disorder neurofibromatosis 2 may reduce the hearing damage that can be exacerbated by radiotherapy...
Researchers have set up a lab-on-a-chip with accompanying automatic analysis software to study gene regulation in single bacterial cells...
Researchers have found evidence in human ovarian tissue that exposure to ibuprofen during the first three months of foetal development results in a dramatic loss of the germ cells...
When thinking about the future of the pharmaceutical sector, it can be difficult to pinpoint a specific focus as there are a wide range of challenges that come into consideration across all stages of development and manufacturing. Dr Lynne Murdoch, Business Manager – Microbiology, Wickham Laboratories, considers some key points....
This issue celebrates European Pharmaceutical Review's 21st birthday through 21 interviews with leading lights from across the pharmaceutical industry...
This white paper discusses the over-arching strategy for performing a successful cleaning validation, with detail on some of the key factors to consider at both the manufacturing, microbiological and analytical stages, highlighting many common pitfalls to avoid..
In recent years, the FDA response to companies with insufficient proof of control over their production has become more aggressive...